Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Peter Kabos

Concepts (380)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
49
2024
1862
6.090
 Why?
Receptors, Estrogen
19
2024
372
3.130
 Why?
Receptor, ErbB-2
12
2024
300
1.850
 Why?
Receptors, Progesterone
11
2020
319
1.300
 Why?
Brain Neoplasms
12
2023
979
1.050
 Why?
Triple Negative Breast Neoplasms
6
2023
157
0.870
 Why?
Keratin-5
6
2022
46
0.870
 Why?
Estrogens
7
2023
312
0.850
 Why?
Biomarkers, Tumor
7
2022
1040
0.840
 Why?
Breast Neoplasms, Male
3
2018
28
0.810
 Why?
Stem Cells
7
2006
545
0.760
 Why?
Neoplasm Metastasis
4
2020
522
0.740
 Why?
Tetrahydronaphthalenes
1
2021
31
0.730
 Why?
Immunoprecipitation
4
2020
151
0.700
 Why?
Antineoplastic Agents, Hormonal
6
2020
138
0.690
 Why?
Benzodiazepines
1
2021
116
0.690
 Why?
Neoplastic Cells, Circulating
1
2020
59
0.680
 Why?
Radiosurgery
3
2023
299
0.680
 Why?
Estrogen Receptor alpha
3
2021
121
0.680
 Why?
Neurons
7
2004
1279
0.680
 Why?
Brain Edema
2
2023
60
0.670
 Why?
Epithelial-Mesenchymal Transition
1
2020
167
0.640
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
49
0.630
 Why?
Leukocytes, Mononuclear
2
2020
493
0.620
 Why?
Gene Expression Profiling
7
2020
1518
0.610
 Why?
Neoplastic Stem Cells
7
2020
329
0.580
 Why?
Gene Expression Regulation, Neoplastic
10
2022
1141
0.580
 Why?
High-Throughput Nucleotide Sequencing
4
2019
439
0.580
 Why?
Female
51
2024
59466
0.580
 Why?
Drug Resistance, Neoplasm
4
2020
636
0.570
 Why?
Antineoplastic Combined Chemotherapy Protocols
8
2024
1355
0.560
 Why?
Polyadenylation
1
2017
37
0.560
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
5
0.560
 Why?
Carcinogenesis
2
2020
177
0.560
 Why?
Organoplatinum Compounds
1
2016
37
0.550
 Why?
Cancer-Associated Fibroblasts
1
2016
10
0.550
 Why?
Fluorouracil
1
2016
152
0.520
 Why?
Artifacts
1
2016
113
0.510
 Why?
Mitochondrial Proteins
1
2017
219
0.510
 Why?
CD146 Antigen
3
2021
35
0.500
 Why?
Thrombocytopenia
1
2016
177
0.480
 Why?
MCF-7 Cells
4
2020
105
0.470
 Why?
Maytansine
1
2014
13
0.470
 Why?
Humans
63
2024
114623
0.460
 Why?
Cell Line, Tumor
14
2020
2710
0.450
 Why?
Tumor Microenvironment
4
2021
430
0.440
 Why?
Analgesics, Opioid
1
2021
771
0.440
 Why?
RNA-Binding Proteins
1
2016
344
0.430
 Why?
Trastuzumab
5
2023
89
0.420
 Why?
Binding Sites
1
2016
1168
0.420
 Why?
Antineoplastic Agents
4
2023
1879
0.420
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
192
0.410
 Why?
Neoplasms, Hormone-Dependent
1
2012
38
0.400
 Why?
Homeodomain Proteins
5
2018
463
0.400
 Why?
Neoplasm Recurrence, Local
5
2021
858
0.400
 Why?
MicroRNAs
5
2016
600
0.390
 Why?
RNA
2
2016
809
0.390
 Why?
Protein Kinase Inhibitors
5
2021
785
0.380
 Why?
Liver Neoplasms
1
2015
506
0.380
 Why?
Chemotherapy, Adjuvant
5
2023
332
0.380
 Why?
Neoadjuvant Therapy
3
2021
304
0.380
 Why?
Antibodies, Monoclonal, Humanized
2
2021
663
0.370
 Why?
Estradiol
3
2015
455
0.370
 Why?
Mutation
3
2021
3344
0.370
 Why?
Colorectal Neoplasms
1
2016
615
0.340
 Why?
Progestins
5
2020
75
0.340
 Why?
Pyrimidines
3
2018
376
0.340
 Why?
Tamoxifen
4
2018
191
0.340
 Why?
Prognosis
7
2021
3328
0.330
 Why?
Adenocarcinoma
1
2015
795
0.320
 Why?
Hydrocephalus
3
2023
83
0.320
 Why?
Carcinoma, Ductal, Breast
2
2020
76
0.310
 Why?
Tumor Cells, Cultured
5
2020
849
0.300
 Why?
Signal Transduction
5
2018
4509
0.300
 Why?
Middle Aged
15
2021
26719
0.300
 Why?
Bone Marrow Cells
2
2014
267
0.300
 Why?
Neoplasm Staging
4
2021
1167
0.280
 Why?
Astrocytes
4
2023
162
0.260
 Why?
Helix-Loop-Helix Motifs
2
2002
11
0.260
 Why?
Necrosis
2
2019
211
0.260
 Why?
Cluster Analysis
4
2019
455
0.250
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
9
0.250
 Why?
Sequence Analysis, RNA
2
2019
385
0.250
 Why?
Neuroglia
2
2003
150
0.240
 Why?
Aged
13
2023
19061
0.240
 Why?
Neoplasm Grading
2
2017
242
0.240
 Why?
Mice, Inbred NOD
5
2021
555
0.230
 Why?
Aromatase Inhibitors
2
2021
49
0.230
 Why?
Animals
25
2021
31694
0.230
 Why?
Carbolines
1
2024
27
0.230
 Why?
Progesterone
3
2014
232
0.220
 Why?
Adult
14
2021
30528
0.220
 Why?
Mice
17
2021
14860
0.220
 Why?
Extracellular Matrix Proteins
1
2004
127
0.210
 Why?
Aquaporin 4
2
2023
87
0.210
 Why?
Keratin-17
1
2022
4
0.210
 Why?
Nerve Regeneration
1
2002
50
0.210
 Why?
Stromal Cells
2
2020
96
0.210
 Why?
Tumor Suppressor Proteins
2
2015
282
0.210
 Why?
Immunoconjugates
1
2023
87
0.200
 Why?
Mice, SCID
4
2020
314
0.200
 Why?
Down-Regulation
4
2015
594
0.200
 Why?
Cell-Free Nucleic Acids
1
2022
26
0.200
 Why?
Neoplasm Invasiveness
3
2020
442
0.200
 Why?
Medicare
3
2023
665
0.200
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.190
 Why?
Genetic Therapy
1
2003
257
0.190
 Why?
Gene Regulatory Networks
2
2014
228
0.190
 Why?
Tumor Suppressor Protein p53
2
2015
445
0.190
 Why?
Cyclins
1
2002
78
0.190
 Why?
Piperazines
1
2024
309
0.190
 Why?
gamma-Aminobutyric Acid
1
2002
144
0.180
 Why?
RNA, Messenger
3
2019
2552
0.180
 Why?
Insulin Receptor Substrate Proteins
1
2020
56
0.180
 Why?
Cell Adhesion Molecules
1
2021
168
0.180
 Why?
Transcriptome
2
2019
725
0.180
 Why?
Pyridines
1
2024
425
0.180
 Why?
Cancer Care Facilities
1
2020
29
0.180
 Why?
Retrospective Studies
5
2023
12542
0.180
 Why?
Antigens, Neoplasm
1
2021
221
0.170
 Why?
Antineoplastic Agents, Immunological
2
2019
152
0.170
 Why?
Meningeal Carcinomatosis
1
2020
8
0.170
 Why?
Hyaluronan Receptors
4
2014
90
0.170
 Why?
SEER Program
1
2021
196
0.170
 Why?
Aged, 80 and over
3
2021
6344
0.170
 Why?
Carcinoma, Lobular
1
2020
44
0.170
 Why?
Aminopyridines
1
2020
81
0.170
 Why?
Gene Library
2
2019
114
0.170
 Why?
Repressor Proteins
1
2002
366
0.170
 Why?
Collagen
2
2020
415
0.170
 Why?
Disease-Free Survival
2
2020
620
0.170
 Why?
Lymphatic Metastasis
2
2017
275
0.170
 Why?
Benzimidazoles
1
2020
138
0.160
 Why?
ErbB Receptors
2
2020
554
0.160
 Why?
Paclitaxel
1
2020
190
0.160
 Why?
Xenograft Model Antitumor Assays
4
2017
698
0.150
 Why?
Treatment Outcome
5
2023
9084
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
48
0.150
 Why?
beta Catenin
1
2020
219
0.150
 Why?
Disease Progression
4
2018
2380
0.150
 Why?
Heterografts
4
2020
117
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2017
76
0.140
 Why?
RNA Polymerase III
1
2017
25
0.140
 Why?
Single-Cell Analysis
1
2019
188
0.140
 Why?
3' Untranslated Regions
1
2017
129
0.140
 Why?
Glioma
3
2006
294
0.140
 Why?
Cell Proliferation
5
2021
2186
0.140
 Why?
Genital Neoplasms, Female
1
2017
70
0.140
 Why?
Pyrroles
1
2017
181
0.140
 Why?
Neoplasms, Radiation-Induced
1
2016
67
0.130
 Why?
Receptors, Androgen
1
2017
131
0.130
 Why?
Ovary
1
2017
191
0.130
 Why?
Gene Expression
2
2016
1421
0.130
 Why?
Combined Modality Therapy
2
2019
1121
0.130
 Why?
Neoplasms, Second Primary
1
2016
92
0.130
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
923
0.130
 Why?
Obesity
2
2018
2507
0.130
 Why?
Ribosomal Proteins
1
2015
70
0.130
 Why?
Proto-Oncogene Proteins c-akt
1
2017
398
0.130
 Why?
Fibroblasts
1
2020
837
0.120
 Why?
Pyrazoles
1
2018
362
0.120
 Why?
Paracrine Communication
1
2015
56
0.120
 Why?
Hodgkin Disease
1
2016
120
0.120
 Why?
DNA Primers
1
2016
510
0.120
 Why?
Risk Reduction Behavior
1
2016
201
0.120
 Why?
Reactive Oxygen Species
1
2017
531
0.120
 Why?
Azepines
1
2015
75
0.120
 Why?
Peptides
1
2020
848
0.120
 Why?
Clinical Decision-Making
1
2017
268
0.120
 Why?
STAT5 Transcription Factor
1
2014
44
0.120
 Why?
Odds Ratio
1
2017
953
0.120
 Why?
Receptors, Steroid
1
2014
47
0.110
 Why?
Opioid-Related Disorders
1
2021
413
0.110
 Why?
Apoptosis
4
2017
2362
0.110
 Why?
Disease Models, Animal
4
2017
3531
0.110
 Why?
DNA-Binding Proteins
2
2015
1314
0.110
 Why?
Male
8
2018
55554
0.110
 Why?
Sensitivity and Specificity
2
2016
1691
0.110
 Why?
United States
4
2023
12176
0.100
 Why?
CD24 Antigen
1
2012
20
0.100
 Why?
Clinical Trials as Topic
1
2017
931
0.100
 Why?
Retinoids
1
2012
31
0.100
 Why?
Comorbidity
1
2017
1448
0.100
 Why?
RNA Interference
1
2014
433
0.100
 Why?
Anthracyclines
2
2023
41
0.100
 Why?
Doxorubicin
3
2022
285
0.100
 Why?
Mitochondria
1
2017
747
0.100
 Why?
Taxoids
2
2023
93
0.100
 Why?
Genome, Human
1
2014
347
0.100
 Why?
Cell Differentiation
3
2004
1700
0.100
 Why?
Small Molecule Libraries
1
2012
79
0.100
 Why?
Rats
5
2017
4958
0.100
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
157
0.100
 Why?
Tumor Burden
1
2012
259
0.090
 Why?
Drug Discovery
1
2012
123
0.090
 Why?
Logistic Models
1
2016
1840
0.090
 Why?
Protein Binding
1
2016
1889
0.090
 Why?
Nuclear Proteins
1
2015
591
0.090
 Why?
Lung Neoplasms
1
2023
2177
0.090
 Why?
Basic Helix-Loop-Helix Transcription Factors
2
2002
225
0.090
 Why?
Dendritic Cells
2
2004
435
0.090
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
740
0.090
 Why?
Estrogen Antagonists
1
2010
39
0.090
 Why?
Transforming Growth Factor beta
1
2012
448
0.080
 Why?
Time Factors
2
2020
6112
0.080
 Why?
BRCA2 Protein
1
2009
41
0.080
 Why?
Cell Culture Techniques
2
2020
342
0.080
 Why?
Pregnancy Complications, Neoplastic
1
2009
50
0.080
 Why?
Thrombophilia
1
2009
67
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1177
0.080
 Why?
Receptors, CXCR4
2
2006
78
0.080
 Why?
Quinolines
2
2021
129
0.080
 Why?
Brain
2
2023
2371
0.080
 Why?
Cells, Cultured
3
2006
3881
0.070
 Why?
Risk Factors
2
2020
8628
0.070
 Why?
Genetic Predisposition to Disease
1
2016
2084
0.070
 Why?
Rats, Sprague-Dawley
2
2002
2218
0.070
 Why?
Proteoglycans
2
2006
107
0.070
 Why?
Drug Delivery Systems
1
2010
296
0.070
 Why?
Radiotherapy, Adjuvant
2
2018
182
0.070
 Why?
Immunohistochemistry
2
2017
1629
0.070
 Why?
Aurora Kinase A
2
2018
51
0.070
 Why?
Severity of Illness Index
1
2014
2537
0.070
 Why?
Tomography, X-Ray Computed
1
2015
2279
0.070
 Why?
Cell Movement
2
2015
868
0.070
 Why?
Biopsy
2
2020
1036
0.060
 Why?
Nervous System
1
2006
63
0.060
 Why?
Rats, Inbred F344
2
2003
241
0.060
 Why?
Mass Spectrometry
2
2020
633
0.060
 Why?
Neoplasm Transplantation
2
2016
228
0.060
 Why?
Infant, Premature, Diseases
1
2006
89
0.060
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.060
 Why?
Aggrecans
1
2004
14
0.060
 Why?
Lectins, C-Type
1
2004
61
0.060
 Why?
Adipose Tissue
2
2018
539
0.060
 Why?
Glioblastoma
2
2006
253
0.060
 Why?
Cyclophosphamide
2
2018
217
0.060
 Why?
Cell Line
2
2014
2635
0.060
 Why?
Mastectomy, Segmental
2
2017
76
0.060
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
7
0.060
 Why?
Aromatase
1
2023
30
0.050
 Why?
Camptothecin
1
2023
96
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
4
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
6
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
52
0.050
 Why?
Pyramidal Tracts
1
2002
20
0.050
 Why?
Edema
1
2023
119
0.050
 Why?
Neurites
1
2002
43
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
9
0.050
 Why?
Phenotype
1
2010
2796
0.050
 Why?
Sciatic Nerve
1
2002
56
0.050
 Why?
Gonadotropin-Releasing Hormone
1
2024
188
0.050
 Why?
Vimentin
1
2022
58
0.050
 Why?
Transcription Factor HES-1
1
2002
4
0.050
 Why?
Neoplasms
1
2015
2097
0.050
 Why?
Frontal Lobe
1
2002
141
0.050
 Why?
Oligonucleotides, Antisense
1
2002
100
0.050
 Why?
Blotting, Western
1
2004
1147
0.050
 Why?
Mice, Inbred BALB C
1
2004
1143
0.050
 Why?
Fibroblast Growth Factors
1
2002
162
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
107
0.050
 Why?
Ependymoma
1
2003
155
0.050
 Why?
Cerebral Cortex
1
2004
380
0.050
 Why?
Protein-Lysine 6-Oxidase
1
2020
6
0.050
 Why?
Nucleosomes
1
2022
123
0.050
 Why?
Clinical Trials, Phase I as Topic
1
2020
45
0.040
 Why?
Mice, Inbred C57BL
3
2004
4689
0.040
 Why?
Hospitals, University
1
2021
172
0.040
 Why?
Membrane Glycoproteins
1
2002
430
0.040
 Why?
Animals, Newborn
1
2002
778
0.040
 Why?
Nervous System Diseases
1
2003
253
0.040
 Why?
Adherens Junctions
1
2020
26
0.040
 Why?
Gene Knockout Techniques
1
2020
98
0.040
 Why?
Protein Interaction Mapping
1
2020
101
0.040
 Why?
Kaplan-Meier Estimate
1
2021
811
0.040
 Why?
Immunotherapy
1
2003
474
0.040
 Why?
Mice, Nude
2
2015
630
0.040
 Why?
Cadherins
1
2020
175
0.040
 Why?
DNA, Complementary
1
2019
256
0.040
 Why?
Loss of Function Mutation
1
2018
36
0.040
 Why?
Maintenance Chemotherapy
1
2018
22
0.040
 Why?
Wnt Signaling Pathway
1
2020
146
0.040
 Why?
Nausea
1
2018
101
0.040
 Why?
Promoter Regions, Genetic
2
2012
1131
0.040
 Why?
Mastectomy
1
2018
99
0.040
 Why?
Breast
1
2018
139
0.040
 Why?
Tumor Necrosis Factor-alpha
1
2002
1139
0.040
 Why?
Antigens, CD
1
2020
442
0.040
 Why?
Phenylthiohydantoin
1
2017
40
0.040
 Why?
Diarrhea
1
2018
171
0.040
 Why?
Mammary Neoplasms, Experimental
1
2017
64
0.040
 Why?
Ovariectomy
1
2017
116
0.030
 Why?
Area Under Curve
1
2017
274
0.030
 Why?
Nitriles
1
2017
149
0.030
 Why?
Benzamides
1
2017
169
0.030
 Why?
Steroids
1
2017
144
0.030
 Why?
Fatigue
1
2018
294
0.030
 Why?
Cell Membrane
1
2020
680
0.030
 Why?
Administration, Oral
1
2018
728
0.030
 Why?
Flow Cytometry
2
2012
1083
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
171
0.030
 Why?
Chromatography, Liquid
1
2017
347
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
56
0.030
 Why?
Postmenopause
1
2017
303
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Weight Gain
1
2018
453
0.030
 Why?
Transcription Factors
1
2002
1528
0.030
 Why?
Software
1
2019
529
0.030
 Why?
Molecular Targeted Therapy
1
2017
347
0.030
 Why?
Gene Knockdown Techniques
1
2015
299
0.030
 Why?
Jagged-1 Protein
1
2014
22
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Wnt-5a Protein
1
2014
18
0.030
 Why?
Argonaute Proteins
1
2014
28
0.030
 Why?
Testosterone
1
2017
343
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
57
0.030
 Why?
Transcription, Genetic
1
2020
1313
0.030
 Why?
Interleukin-6
1
2017
676
0.030
 Why?
Cellular Microenvironment
1
2014
78
0.030
 Why?
Gene Expression Regulation
1
2022
2319
0.030
 Why?
Socioeconomic Factors
1
2017
1077
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
308
0.030
 Why?
Guideline Adherence
1
2017
490
0.030
 Why?
Wnt Proteins
1
2014
134
0.030
 Why?
Acitretin
1
2012
3
0.030
 Why?
Miconazole
1
2012
4
0.030
 Why?
Biomarkers
2
2017
3408
0.030
 Why?
Calcium-Binding Proteins
1
2014
206
0.030
 Why?
Isotretinoin
1
2012
22
0.030
 Why?
Stem Cell Transplantation
2
2004
149
0.030
 Why?
Magnetic Resonance Imaging
2
2019
3039
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
351
0.020
 Why?
Luciferases
1
2012
142
0.020
 Why?
Genes, Reporter
1
2012
257
0.020
 Why?
Risk Assessment
1
2020
2967
0.020
 Why?
Tretinoin
1
2012
122
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
498
0.020
 Why?
Diet
1
2018
1080
0.020
 Why?
Follow-Up Studies
1
2020
4411
0.020
 Why?
Colorado
1
2020
4099
0.020
 Why?
Green Fluorescent Proteins
1
2012
371
0.020
 Why?
HEK293 Cells
1
2012
591
0.020
 Why?
Proto-Oncogene Proteins
1
2014
608
0.020
 Why?
Hypertension
1
2018
1056
0.020
 Why?
Age Factors
1
2017
2894
0.020
 Why?
Base Sequence
1
2014
2114
0.020
 Why?
Practice Guidelines as Topic
1
2017
1394
0.020
 Why?
Pregnancy Trimester, Second
1
2009
66
0.020
 Why?
Molecular Sequence Data
1
2014
2785
0.020
 Why?
Pregnancy Trimester, First
1
2009
125
0.020
 Why?
Endothelial Cells
1
2014
681
0.020
 Why?
Lymph Node Excision
1
2009
139
0.020
 Why?
Membrane Proteins
1
2014
1018
0.020
 Why?
Transplantation, Heterologous
1
2008
181
0.020
 Why?
Neoplasms, Experimental
1
2008
151
0.020
 Why?
Infant, Newborn
2
2009
5043
0.020
 Why?
Chemokines, CXC
1
2006
60
0.020
 Why?
Nestin
1
2006
16
0.020
 Why?
Laminin
1
2006
69
0.020
 Why?
Chemokine CXCL12
1
2006
74
0.020
 Why?
Intermediate Filament Proteins
1
2006
65
0.020
 Why?
Glial Fibrillary Acidic Protein
1
2006
79
0.020
 Why?
Lasers
1
2006
121
0.020
 Why?
Drug Combinations
1
2006
287
0.020
 Why?
Culture Media, Conditioned
1
2004
105
0.010
 Why?
RNA, Small Interfering
1
2006
535
0.010
 Why?
Injections, Intralesional
1
2003
32
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
40
0.010
 Why?
beta-Galactosidase
1
2002
62
0.010
 Why?
Models, Neurological
1
2004
212
0.010
 Why?
Nerve Tissue Proteins
1
2006
529
0.010
 Why?
Infant, Premature
1
2006
476
0.010
 Why?
Random Allocation
1
2003
335
0.010
 Why?
Reference Values
1
2003
742
0.010
 Why?
Case-Control Studies
1
2006
3003
0.010
 Why?
Survival Rate
1
2003
1644
0.010
 Why?
Pregnancy
1
2009
5517
0.010
 Why?
Vaccination
1
2003
1204
0.010
 Why?
Prospective Studies
1
2006
6217
0.010
 Why?
Infant
1
2006
7959
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (380) concept(s)
_
Co-Authors Expand Description
See all (61) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)